Enhanced Recovery After Surgery in Major Intrabdominal Procedures.
|ClinicalTrials.gov Identifier: NCT01400711|
Recruitment Status : Completed
First Posted : July 22, 2011
Last Update Posted : July 22, 2011
Enhanced Recovery After Surgery (ERAS) programs have been introduced with aims of attenuating the stress response to surgery and enabling rapid recovery. There is strong evidence of the usefulness of the ERAS programs in patients undergoing colorectal surgery in terms of significantly reduced postoperative complications and shorter length of hospital stay, compared to the patients of traditional treatment. However, few studies exist about the implication of ERAS programs in major upper abdominal surgery patients.
The aim of this study was to compare morbidity, mortality and length of stay in patients undergoing major intrabdominal surgery, including upper and lower gastrointestinal, receiving either conventional postoperative care or an ERAS program.
|Condition or disease||Intervention/treatment|
|Complication of Surgical and Medical Care.||Other: ERAS perioperative care Other: Traditional|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||54 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Enhanced Recovery After Surgery (ERAS) Versus Conventional Postoperative Care in Patients Undergoing Major Intra-abdominal Surgery.|
|Study Start Date :||October 2010|
|Primary Completion Date :||March 2011|
|Study Completion Date :||April 2011|
Active Comparator: ERAS patients
Patients planned to undergoing major intrabdominal surgery, following the ERAS perioperative care.
Other: ERAS perioperative care
Patient's education before surgery, early mobilization and oral feeding after surgery, no opioids analgesics.
Active Comparator: Control patients
Patients planned to undergo major intrabdominal surgery, following the conventional perioperative care.
Nasogastric tube until bowel function, late oral eating, opioid analgesics.
- Morbidity. [ Time Frame: 30 days after surgery ]
- Mortality. [ Time Frame: 30 days after surgery ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01400711
|St. Andrew General Hospital, Department of Surgery|
|Patra, Greece, 26441|